Mechanism of action: Activates dopamine receptors in the brain, regulating dopamine levels.
Uses:
Hyperprolactinemia
Parkinson's disease
Acromegaly
Neuroleptic malignant syndrome (NMS)
Type 2 diabetes (off-label use)
Contraindications:
Hypersensitivity to Sicriptin 1.25mg tablet or any of its components
Uncontrolled hypertension (high blood pressure)
Postpartum hypertension or a history of toxemia of pregnancy
Cardiovascular disorders, including angina, myocardial infarction, or peripheral vascular disease
Psychiatric disorders
Precautions:
Store at room temperature, between 20°C to 25°C (68°F to 77°F)
Keep away from moisture, heat, and light
Do not freeze
Keep away from children and pets
Inform the doctor about all medications, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products
Dosage and administration:
Take exactly as prescribed by a healthcare professional
Dosage and frequency depend on the medical condition being treated
Can be taken with or without food
Do not adjust the dosage or stop taking it without medical guidance
Safety advices:
Pregnancy: Discuss all potential risks and benefits with a healthcare provider
Breastfeeding: Use should be carefully evaluated and monitored by a healthcare professional
Lungs: Consult with a qualified healthcare professional if you have a lung-related medical condition
Liver: Inform your healthcare provider about liver-related medical conditions before starting Sicriptin 1.25mg tablet
Alcohol: Combining with alcohol is generally not recommended
Driving: The use of Sicriptin 1.25mg tablet may cause side effects that can impair cognitive and motor skills
Side effects:
Serious: Hallucinations or confusion, mental/mood changes, difficulty breathing, uncontrolled movements or twitching (dyskinesias), chest pain or rapid heart rate, fainting or loss of consciousness, yellowing of the skin or eyes (jaundice), signs of liver problems (e.g., dark urine, pale stools), signs of an allergic reaction (e.g., rash, itching, swelling, severe dizziness)
Common: Nausea, vomiting, headache, dizziness, fatigue or drowsiness, lightheadedness, abdominal discomfort or pain, dry mouth, constipation, changes in blood pressure (both low and high blood pressure), swelling in the legs or ankles
FAQs:
Q 1. Can Sicriptin 1.25mg tablet treat menstrual migraines?
Sicriptin 1.25mg tablet has been studied for its potential to reduce the frequency and severity of menstrual migraines, although it is not a primary treatment for this condition. However, its use should be determined by a healthcare professional based on individual needs and medical history.
Q 2. Can I safely use Sicriptin 1.25mg tablet if I have a history of cardiovascular issues?
Patients with a history of cardiovascular disorders, such as heart disease or uncontrolled hypertension, need to exercise caution while using Sicriptin 1.25mg tablet due to its potential to cause changes in blood pressure. It is crucial to inform your healthcare provider about your medical history before starting the medication, as they can closely monitor your condition and make necessary adjustments to ensure your safety. Avoid self-medicating and always follow your healthcare provider's advice for the safe use of it.
Q 3. Is weight gain a common side effect of Sicriptin 1.25mg tablet?
Weight gain is not a common side effect of Sicriptin 1.25mg tablet. It is more often associated with weight loss due to its effect on regulating appetite and metabolism. However, individual responses to medications can vary, and some patients may experience weight changes while taking it.
Q 4. Is Sicriptin 1.25mg tablet available as a nasal spray or injection?
While Sicriptin 1.25mg tablet is primarily available in oral tablet or capsule forms, in some cases, healthcare providers may prescribe it as a nasal spray or injection for specific medical conditions. The form of administration will depend on the patient's needs and treatment goals.
Q 5. Can Sicriptin 1.25mg tablet be used for weight loss?
Sicriptin 1.25mg tablet has been investigated for its potential in weight management due to its effect on regulating appetite and metabolism. However, its use for weight loss is not approved, and more research is needed to determine its safety and efficacy in this context.
Q 6. Can Sicriptin 1.25mg tablet be used for managing prolactinomas in men?
While hyperprolactinemia and prolactinomas are more common in women, Sicriptin 1.25mg tablet can also be used to manage prolactinomas in men. As with any medical treatment, individualized care and supervision are essential.
-200x200.jpg "Feruno 500mg Injection")
